Location: Home
  • search
  • go
  • Relate News
  • 11/30/2021Adagene Gains U.S. IND Approval for P1b/2 Trial of Anti-CTLA-4 mAb A...
  • 11/30/2021Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Market in ...
  • 11/30/2021NH's DB6: Pandemic Continues to Dictate CHC Trends with China Recoveri...
  • 11/29/2021NHSA Issues Three-Year Action Plan on DRD/DIP Payment System Reform (S...
  • 11/26/2021Luye Subsidiary Boan Bio Signs MOU with Merck to Build Next-Gen Digit...
  • 11/26/2021Simcere Announces CN Conditional Approval of Enweida (Envafolimab) C...
  • 11/26/2021Recent Executive Movements
  • 11/24/2021HUTCHMED and AZ Initiate SACHI P3 Trial of ORPATHYS and TAGRISSO Com...
  • 11/24/2021NMPA Announces Package Insert Revision of Disodium Clodronate Formulat...
  • 11/24/2021BeiGene Completes Acquisition of Former BMS Campus in NJ
  • 11/24/2021API Manufacturers Targeted by China's New Anti-monopoly Bureau: Pharma...
  • 11/23/2021PharmaDJ's China Licensing Deals Tracker: October 2021
  • 11/23/2021NHC Issues Notice on Promotion of Sanming City's Healthcare Reform Exp...
  • 11/23/2021Ji Xing Granted Chinese IND Approval for Phase 1 & 3 Trials of Etripam...
  • 11/23/2021Lonza and Bluejay Therapeutics Ink Manufacturing Deal
  • 11/23/2021Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from...
  • 11/22/2021CStone and Hengrui Enter Licensing Pact on Anti-CTLA-4 mAb CS1002 in ...
  • 11/22/2021Independent Directors of Kangmei Pharma Fined Heavily, Triggering A Qu...
  • 11/22/2021Sanofi and Baidu Enter License Agreement for Next-Generation mRNA Th...
  • 11/19/2021GSK Secures Chinese Approval of Nucala (mepolizumab) for EPGA
  • 11/19/2021State Council Issues the Opinions for Improving Critical Illness Medic...
  • 11/18/2021Performance Data Review of A Share-Listed Chinese Healthcare Companies...
  • 11/18/2021Data Review of Chinese Public Medical Institution Drug Sales in H1/202...
  • 11/18/2021Bright Peak Licenses Livzon's Antibody LZM009 to Develop Novel PD-1 Ta...
  • 11/18/2021China Launches the State Anti-monopoly Bureau as It Issues the Guideli...
  • 11/18/2021China Healthcare Summit: Western Investors Expand into Chinese Biotech...
  • 11/17/2021Kangmei Pharma Executives Sentenced to Jail
  • 11/16/2021I-Mab and Jumpcan Announce Strategic Commercial Partnership on Eftanso...
  • 11/16/2021Amgen Enters into Strategic Collaboration with Profex to Co-promote Pr...
  • 11/16/2021Innovent's 5th NDA for PD-1 Drug Tyvyt Turned Down by the NMPA 
  • Page:81/361 Total number of articles:10809: [First][<<] [79] [80] [81] [82] [83] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group